POS-336 THE IMPACT OF CHRONIC KIDNEY DISEASE AND CLINICAL EVENTS ON PATIENT HEALTH RELATED QUALITY OF LIFE IN DAPA-CKD
P. MCEWAN,
O. Darlington,
J. Garcia-Sanchez,
N. Rao,
D. Wheeler,
H. Heerspink
Affiliations
P. MCEWAN
HEOR, Health Economics and Outcomes Research, Cardiff, United Kingdom
O. Darlington
HEOR, Health Economics and Outcomes Research, Cardiff, United Kingdom
J. Garcia-Sanchez
AstraZeneca, AstraZeneca, Cambridge, United Kingdom
N. Rao
AstraZeneca, AstraZeneca, Cambridge, United Kingdom
D. Wheeler
University College London, Department of Renal Medicine, London, United Kingdom; George Institute for Global Health, George Institute, Sydney, Australia
H. Heerspink
George Institute for Global Health, George Institute, Sydney, Australia; University of Groningen, Department of Clinical Pharmacy and Pharmacology- University Medical Center Groningen, Groningen, Netherlands
